Fusion Antibodies plc
FAB.L · LSE
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | £0 | £1 | £0 | £2 |
| Short-Term Investments | £0 | £0 | £0 | £0 |
| Receivables | £0 | £1 | £1 | £2 |
| Inventory | £0 | £0 | £1 | £1 |
| Other Curr. Assets | £0 | £0 | £0 | £0 |
| Total Curr. Assets | £1 | £2 | £2 | £4 |
| Property Plant & Equip (Net) | £0 | £0 | £0 | £1 |
| Goodwill | £0 | £0 | £0 | £0 |
| Intangibles | £0 | £0 | £0 | £0 |
| Long-Term Investments | £0 | £0 | £0 | £0 |
| Tax Assets | £0 | £0 | £0 | £0 |
| Other NC Assets | £0 | £0 | £0 | £0 |
| Total NC Assets | £0 | £0 | £0 | £1 |
| Other Assets | £0 | £0 | £0 | £0 |
| Total Assets | £1 | £2 | £2 | £5 |
| Liabilities | – | – | – | – |
| Payables | £0 | £0 | £0 | £0 |
| Short-Term Debt | £0 | £0 | £0 | £0 |
| Tax Payable | £0 | £0 | £0 | £0 |
| Deferred Revenue | £0 | £0 | £0 | £0 |
| Other Curr. Liab. | £0 | £0 | £0 | £1 |
| Total Curr. Liab. | £1 | £1 | £1 | £1 |
| LT Debt | £0 | £0 | £0 | £0 |
| Deferred Rev, NC | £0 | £0 | £0 | £0 |
| Deferred Tax Liab, NC | £0 | £0 | £0 | £0 |
| Other NC Liab. | £0 | £0 | £0 | £0 |
| Total NC Liab. | £0 | £0 | £0 | £0 |
| Other Liabilities | £0 | £0 | £0 | £0 |
| Cap. Leases | £0 | £0 | £0 | £0 |
| Total Liabilities | £1 | £1 | £1 | £1 |
| Equity | – | – | – | – |
| Pref Stock | £0 | £0 | £0 | £0 |
| Common Stock | £4 | £4 | £1 | £1 |
| Retained Earnings | -£11 | -£10 | -£8 | -£5 |
| AOCI | £0 | £0 | £0 | £0 |
| Other Equity | £8 | £8 | £8 | £8 |
| Total Equity | £1 | £2 | £1 | £4 |
| Supplemental Information | – | – | – | – |
| Minority Interest | £0 | £0 | £0 | £0 |
| Total Liab. & Tot. Equity | £1 | £2 | £2 | £5 |
| Net Debt | -£0 | -£1 | -£0 | -£2 |